Lumenis Ltd has acquired Pollogen Ltd, an Israeli-based medical aesthetic company.
Pollogen’s product line, including OxyGeneo®, VoluDerm™, Hybrid Energy™, TriPollar®, TriLipo® and TriFractional™, will augment Lumenis’ energy-based portfolio of laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF) technologies.
